Skip to main content
. 2022 Jun 17;1(6):1014–1026. doi: 10.1016/j.gastha.2022.06.008

Table 2.

Imaging-Related Characteristics of Study Subjects Presented on or Before t0, Extracted by Natural Language Processing (NLP; n = 46,041)

Patient characters related to image n (%)
Imaging features (mutually inclusive) at or before index scan:
Atrophy 14,343 (31.2)
Calcification 12,637 (27.4)
Cyst 14,661 (31.8)
Duct dilatation 10,413 (22.6)
Pseudocyst 4435 (9.6)
Imaging features (mutually exclusive) at or before index scan:
 Single
 Calcification only 9437 (20.5)
 Duct dilatation only 6667 (14.5)
 Atrophy only 11,026 (23.9)
 Cyst only 9269 (20.1)
 Pseudocyst only 1636 (3.6)
 Two or more
 Calcification + duct dilatation (w/ or wo/ atrophy, cyst, pseudocyst) 1197 (2.6)
 Calcification + any 1 or more of (atrophy, cyst, pseudocyst) 2003 (4.4)
 Duct dilatation + any 1 or more of (atrophy, cyst, pseudocyst) 2549 (5.5)
 Any 2 or more of (atrophy, cyst, pseudocyst) 2257 (4.9)
Type of service at index scan
 Outpatient/ED 35,802 (77.8)
 Inpatient 10,239 (22.2)
Index scan modality
 CT 39,288 (85.3)
 MRI 6753 (14.7)
Indication for the index scan (mutually inclusive)
 Abdominal pain 11,622 (25.2)
 Other pain 5037 (10.9)
 GI problem 6022 (13.1)
 Concern raised by laboratory test results 4568 (9.9)
 Follow-up 3661 (8.0)
 Urinary problem 2323 (5.1)
 Consultation 2055 (4.5)
 Shortness of breath 950 (2.1)
 Weakness 930 (2.0)
 Fever 749 (1.6)
 Nonpancreatic cancer 453 (1.0)
 Others 9496 (20.6)
 Unknown 9108 (19.8)